Durso succeeding Garg as Altimmune CEO 

Vipin Garg will step down as president and CEO of Altimmune Inc. (NASDAQ:ALT) on Jan. 1 after seven years leading the liver and metabolic disease company. Jerry Durso will take on Garg’s roles while remaining chairman.

Circle Pharma Inc. hired Anne Borgman as CMO. A veteran leader of oncology drug development teams, Borgman most recently held the same title at Sutro Biopharma Inc. (NASDAQ:STRO). South San Francisco-based Circle is developing macrocycle therapies for cancer...